News & Updates

Clopidogrel is more effective than aspirin monotherapy in secondary prevention of clinical, ischaemic, and bleeding events in patients who underwent percutaneous coronary intervention (PCI), and this beneficial effect persists across high-risk subgroups, a study has shown.

Genetic predisposition appears to moderate the association between egg consumption and increased risk of coronary artery disease (CAD), suggests a study.

A continuation strategy with antiplatelet therapy (APT) appears to reduce net adverse clinical events (NACE) and major adverse cardiovascular events (MACE) at 30 days in patients undergoing noncardiac surgery within a year after percutaneous coronary intervention (PCI), with a similar incidence of major bleeding, relative to an APT discontinuation strategy, a recent study has shown.

A recent study has found no significant differences in the outcomes among recipients of heart transplant donation after circulatory death (DCD) and those of heart donation after brain death (DBD).

In patients with non–ST-segment–elevation myocardial infarction (NSTEMI), the rates of mortality and ischaemic events appear to be comparable following procedural anticoagulation with bivalirudin vs heparin, although bivalirudin is associated with fewer serious bleeding events, according to the results of a meta-analysis.